The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
作者信息
Young Christina B, Cholerton Brenna, Smith Alena M, Shahid-Besanti Marian, Abdelnour Carla, Mormino Elizabeth C, Hu Shu-Ching, Chung Kathryn A, Peterson Amie, Rosenthal Liana, Pantelyat Alexander, Dawson Ted M, Quinn Joseph, Zabetian Cyrus P, Montine Thomas J, Poston Kathleen L
出版信息
Neurology. 2025 Jun;104(11):e213648. doi: 10.1212/WNL.0000000000213648. Epub 2025 May 12.
Abstract
摘要
相似文献
1
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Neurology. 2025 Jun;104(11):e213648. doi: 10.1212/WNL.0000000000213648. Epub 2025 May 12.
2
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Neurology. 2024 Jul 23;103(2):e209609. doi: 10.1212/WNL.0000000000209609. Epub 2024 Jun 13.
3
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
4
Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature.
Eur J Neurol. 2017 Apr;24(4):561-e20. doi: 10.1111/ene.13258. Epub 2017 Feb 21.
5
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.
Lancet Neurol. 2025 Jul;24(7):580-590. doi: 10.1016/S1474-4422(25)00157-7.
6
Understanding the Patient Experience of Advanced Parkinson's Disease: Qualitative Research with Patients and Expert Clinicians to Identify Symptoms and Associated Health-Related Quality of Life Impacts.
Neurol Ther. 2025 May 13. doi: 10.1007/s40120-025-00747-5.
7
Anticholinergics for symptomatic management of Parkinson's disease.
Cochrane Database Syst Rev. 2003;2002(2):CD003735. doi: 10.1002/14651858.CD003735.
8
Wearable sensor use for assessing standing balance and walking stability in people with Parkinson's disease: a systematic review.
PLoS One. 2015 Apr 20;10(4):e0123705. doi: 10.1371/journal.pone.0123705. eCollection 2015.
9
The Effects of Different Exercise Interventions on Patients with Subjective Cognitive Decline: A Systematic Review and Network Meta-Analysis.
J Prev Alzheimers Dis. 2024;11(3):620-631. doi: 10.14283/jpad.2024.65.
10
Predictors of Improvement in Subjective Executive Functioning Following an Internet-Delivered Cognitive Enhancement Intervention for Adults in Remission From Depression.
Acta Psychiatr Scand. 2025 Jul 20. doi: 10.1111/acps.70019.
本文引用的文献
1
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
Neurology. 2024 Jul 23;103(2):e209609. doi: 10.1212/WNL.0000000000209609. Epub 2024 Jun 13.
Zotero 插件